Joseph Emil Amegadzie

7PUBLICATIONS
11CO-AUTHORS
Time-series analysisRespiratory diseasesPredictive and prognostic markersBehavioural epidemiologyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 28, 2024
20-year trends in excess costs of COPD.

Joseph Emil Amegadzie, Jeenat Mehareen, Amir Khakban

|Dec 05, 2023
QRISK3 underestimates the risk of cardiovascular events in patients with COPD.

Joseph Emil Amegadzie, Zhiwei Gao, Jennifer K Quint

|Jun 01, 2022
Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.

Joseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell

|Oct 16, 2020
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study.

Joseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell

|Nov 01, 2019
Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis.

Joseph Emil Amegadzie, Jessica Gorgui, Lily Acheampong

|Mar 16, 2019
Validated methods to identify patients with asthma-COPD overlap in healthcare databases: a systematic review protocol.

Joseph Emil Amegadzie, Oluwatosin Badejo, John-Michael Gamble

Pageof 2

Frequent Collaborators

3 joint publications

John-Michael Gamble

3 joint publications

Zhiwei Gao

3 joint publications

Mohsen Sadatsafavi

2 joint publications

Jamie Farrell